title: Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Alberti
authors.forename: Nathan
authors.initials: N
authors.lastname: Clumeck
authors.forename: Simon
authors.initials: S
authors.lastname: Collins
authors.forename: Wolfram
authors.initials: W
authors.lastname: Gerlich
authors.forename: Jens
authors.initials: J
authors.lastname: Lundgren
authors.forename: Giorgio
authors.initials: G
authors.lastname: Palù
authors.forename: Peter
authors.initials: P
authors.lastname: Reiss
authors.forename: Rodolphe
authors.initials: R
authors.lastname: Thiebaut
authors.forename: Ola
authors.initials: O
authors.lastname: Weiland
authors.forename: Yazdan
authors.initials: Y
authors.lastname: Yazdanpanah
authors.forename: Stefan
authors.initials: S
authors.lastname: Zeuzem
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D005060:Europe; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans
chemical_list: D019380:Anti-HIV Agents; D000998:Antiviral Agents